Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine to Treat Patients With Post-comatose Disorders of Consciousness
Sponsor: University of Liege
Summary
The investigators will run a Randomized Clinical Trial with 30 patients with disorders of consciousness (DoC), with intravenous subanesthetic doses of ketamine. Patients will simultaneously undergo TMS-EEG. The piloting will be done on 3 patients, with EEG only.
Official title: Complexity-enhancing Drugs to Treat Disorders of Consciousness (DoC): a Ketamine Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-05-01
Completion Date
2026-05-01
Last Updated
2022-11-07
Healthy Volunteers
No
Conditions
Interventions
Ketalar 50 MG/ML Injectable Solution
Intravenous solution (other info already provided)
Placebo
Saline Solution
Locations (1)
Centre Hospitalier Neurologique William Lennox
Ottignies-Louvain-la-Neuve, Wallonia, Belgium